Pharma channel feed – Endpoints News

Pharma channel feed

2019 a 'transformative year' for pharma M&A. Is that a good thing?

6 years ago

Roche cracks China's ADC market open as Kadcyla scores its first breast cancer OK in the country

6 years ago

Wuhan virus outbreak triggers inevitable small-biotech rally

6 years ago

Eli Lilly reserves $470M for new manufacturing plant — and North Carolina is more than pleased

6 years ago

FDA hands off its latest whirlwind drug OK as Horizon hustles would-be blockbuster to the market

6 years ago

AstraZeneca plans to spend $535M-plus to expand its R&D network and manufacturing ops in France

6 years ago

Bernie Sanders goes after BioMarin's shot at a record drug price, threatening to break the patent

6 years ago

GSK, Pfizer contradict on the future of consumer health JV — report

6 years ago

Warren and Klobuchar say they can lower drug prices without Congress’ help

6 years ago

AbbVie's Skyrizi hangs Novartis' Cosentyx out to dry in head-to-head psoriasis study

6 years ago

#JPM20: 'The NPV is always wrong.' Takeda preps another spinout — this time on psych

6 years ago

Roche aims to 'underwhelm' with risdiplam price as it enters SMA rivalry with Biogen, Novartis — report

6 years ago

Amarin's Vascepa reigns supreme in fish oil battle, as AstraZeneca's rival fizzles

6 years ago

Alexis Borisy has $200M to back a market-based plan aimed at curing America’s drug pricing ‘sickness’

6 years ago

J&J plans to recruit a new generation of 'bilingual' scientists for a research facility blueprinted for the booming Bay Area

6 years ago

Blueprint scores first FDA OK for a precision GIST cancer drug, just ahead of a rival treatment. And the price is a big surprise

6 years ago

Merck's Keytruda wins another first — this time for an FDA nod to treat a subset of bladder cancer patients

6 years ago

Steepest decline in US cancer mortality ever recorded, study finds

6 years ago

Vascepa sparkle set to light up Amarin's fourth quarter revenue

6 years ago

The list gets longer: Merck, Allergan, Novartis issue 2020 drug price hikes — report

6 years ago

FDA offers AstraZeneca a shortcut on a landmark SGLT2 approval while China greenlights Lokelma

6 years ago

BeiGene scores first China OK with PD-1 — to be manufactured by Boehringer Ingelheim

6 years ago

New year, new (higher) drug prices

6 years ago

Here are the 52 new drugs approved by the FDA in 2019. Who won? Who lost? And who just survived to 2020?

6 years ago

First page Previous page 261 262 263264265 266 267 Next page Last page